News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
885,331 Results
Type
Article (88906)
Company Profile (724)
Press Release (795682)
Multimedia
Podcasts (243)
Webinars (36)
Section
Business (233645)
Career Advice (4164)
Deals (40017)
Drug Delivery (181)
Drug Development (91766)
Employer Resources (207)
FDA (18591)
Job Trends (17495)
News (398858)
Policy (40022)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3059)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (211)
Alliances (56990)
ALS (242)
Alzheimer's disease (1995)
Antibody-drug conjugate (ADC) (580)
Approvals (18978)
Artificial intelligence (904)
ASCO (345)
Autoimmune disease (381)
Automation (69)
Bankruptcy (409)
Best Places to Work (12635)
BIO (78)
BIOSECURE Act (23)
Biosimilars (256)
Biotechnology (432)
Bladder cancer (215)
Brain cancer (86)
Breast cancer (856)
Cancer (6758)
Cardiovascular disease (568)
Career advice (3601)
Career pathing (53)
CAR-T (392)
CDC (77)
Celiac Disease (3)
Cell therapy (1100)
Cervical cancer (58)
Clinical research (79313)
Collaboration (2442)
Commercialization (1)
Company closure (8)
Compensation (1576)
Complete response letters (110)
COVID-19 (3044)
CRISPR (128)
C-suite (1342)
Cystic fibrosis (169)
Data (8926)
Decentralized trials (3)
Denatured (93)
Depression (201)
Dermatology (101)
Diabetes (722)
Diagnostics (7632)
Digital health (72)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (458)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (331)
Earnings (102543)
Editorial (81)
Employer branding (25)
Employer resources (177)
Events (138936)
Executive appointments (1221)
FDA (22824)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (2011)
Gene editing (279)
Generative AI (92)
Gene therapy (867)
GLP-1 (1296)
Government (5570)
Grass and pollen (8)
Guidances (426)
Healthcare (21272)
Hematology (198)
HIV (100)
Huntington's disease (69)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (118)
Immunology and inflammation (365)
Immuno-oncology (121)
Indications (225)
Infectious disease (3452)
Inflammatory bowel disease (246)
Inflation Reduction Act (17)
Influenza (154)
Intellectual property (332)
Interviews (822)
IPO (18009)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (24)
Labor market (126)
Layoffs (694)
Leadership (54)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (891)
Lymphoma (488)
Machine learning (70)
Management (68)
Manufacturing (1287)
Marketing (4)
MASH (231)
Medical affairs (1)
Medical device (15304)
Medtech (15488)
Mergers & acquisitions (23351)
Metabolic disorders (1865)
mRNA (277)
Multiple sclerosis (211)
NASH (24)
Neurodegenerative disease (527)
Neuropsychiatric disorders (132)
Neuroscience (3799)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5147)
Now hiring (84)
Obesity (886)
Opinion (381)
Ovarian cancer (251)
Pain (289)
Pancreatic cancer (374)
Parkinson's disease (429)
Partnered (42)
Patents (680)
Patient recruitment (812)
Peanut (72)
People (68161)
Pharmaceutical (115)
Pharmacy benefit managers (38)
Phase 1 (24511)
Phase 2 (34454)
Phase 3 (25903)
Pipeline (10209)
Policy (405)
Postmarket research (3560)
Preclinical (11003)
Press Release (72)
Prostate cancer (355)
Psychedelics (73)
Radiopharmaceuticals (378)
Rare diseases (1324)
Real estate (7463)
Recruiting (82)
Regulatory (30627)
Reports (77)
Research institute (2776)
Resumes & cover letters (654)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (198)
Series A (344)
Series B (251)
Service/supplier (24)
Sickle cell disease (132)
Special edition (33)
Spinal muscular atrophy (192)
Sponsored (55)
Startups (4376)
State (2)
Stomach cancer (21)
Supply chain (150)
Tariffs (104)
The Weekly (147)
Vaccines (1334)
Venture capital (142)
Weight loss (605)
Women's health (147)
Worklife (25)
Date
Today (9)
Last 7 days (502)
Last 30 days (2196)
Last 365 days (33152)
2026 (17787)
2025 (33217)
2024 (38031)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (101)
Alaska (7)
Arizona (410)
Arkansas (16)
Asia (52419)
Australia (9210)
California (14640)
Canada (4108)
China (1637)
Colorado (630)
Connecticut (650)
Delaware (453)
Europe (120872)
Florida (2192)
Georgia (475)
Hawaii (4)
Idaho (70)
Illinois (1286)
India (107)
Indiana (673)
Iowa (27)
Japan (624)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1770)
Massachusetts (10727)
Michigan (428)
Minnesota (817)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (157)
New Hampshire (92)
New Jersey (3879)
New Mexico (35)
New York (3867)
North Carolina (1964)
North Dakota (11)
Northern California (7304)
Ohio (460)
Oklahoma (27)
Oregon (55)
Pennsylvania (2872)
Puerto Rico (33)
Rhode Island (55)
South America (1669)
South Carolina (89)
South Dakota (2)
Southern California (5762)
Tennessee (240)
Texas (2392)
United States (52391)
Utah (438)
Vermont (2)
Virginia (377)
Washington D.C. (89)
Washington State (1195)
West Virginia (4)
Wisconsin (161)
Wyoming (2)
There are 885,331 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
5 molecular glues that could stick—and the companies stuck in
Molecular glue degraders are gaining traction in the clinic as well as funding from Big Pharma, with their potential to treat previously “undruggable” cancers and immunological diseases. Here are five clinical programs worth keeping an eye on.
July 6, 2026
·
6 min read
·
Michael Gibney
Opinion
The FDA must put biotech at its center or continue to cede early research to China
Last month, the FDA launched TrialBlazer, intended to streamline the IND path and bring early clinical trials and medical innovation home to the U.S. It’s a start, but new agency leadership must see it through.
July 6, 2026
·
4 min read
·
Kendalle Burlin O’Connell
FDA
Despite chaos and churn, FDA decisions hold mostly steady in H1 2026
Significant leadership instability at the FDA—compounded by continued workforce attrition—led to a slight slowdown in overall regulatory productivity in the first half of this year, but the agency has been catching up of late.
July 6, 2026
·
8 min read
·
Tristan Manalac
Press Releases
Ascletis Submits Two IND Applications to the U.S. FDA for the Treatment of Obesity: ASC36 Once-Monthly Injection, a Peptide Amylin Receptor Agonist, and ASC36_35 FDC Once-Monthly Injection, a Co-Formulation of ASC36 Plus Peptide GLP-1R/GIPR Agonist ASC35
July 5, 2026
·
5 min read
Press Releases
InnoCare Announces First Patient Dosed in Clinical Trial of Novel CDH17 targeted ADC ICP-B208 in China
July 5, 2026
·
2 min read
Press Releases
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 3, 2026
July 5, 2026
·
2 min read
Press Releases
Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
July 5, 2026
·
4 min read
Press Releases
Medicure Announces CFO Change
July 5, 2026
·
5 min read
Press Releases
Ascelia Pharma Provides Update on the Orviglance NDA
July 5, 2026
·
1 min read
Press Releases
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 3, 2026
July 3, 2026
·
1 min read
1 of 88,534
Next
